{"schema_version":"secwatch.filing_event.v1","accession":"0001728117-24-000059","form_type":"8-K","ticker":"GOSS","cik":"0001728117","company_name":"Gossamer Bio, Inc.","filed_at":"2024-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.768917+00:00","generated_at":"2026-06-01T08:46:13.999230+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Gossamer Bio receives Nasdaq minimum bid deficiency; cure period to Nov 18, 2024","bullets":["Nasdaq notice on May 22, 2024; stock below $1.00 for 30 consecutive business days through May 21.","Company has 180 calendar days, until November 18, 2024, to regain compliance.","To cure, closing bid must be at least $1.00 for ten consecutive business days.","If not cured, may transfer to Nasdaq Capital Market for additional 180 days or face delisting.","Company may consider a reverse stock split to address the deficiency."],"urls":{"canonical":"https://secwatch.observer/filing/0001728117-24-000059","json":"https://secwatch.observer/filing/0001728117-24-000059.json","markdown":"https://secwatch.observer/filing/0001728117-24-000059.md","text":"https://secwatch.observer/filing/0001728117-24-000059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728117/000172811724000059/0001728117-24-000059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728117/000172811724000059/goss-20240522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T08:46:13.999230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}